FLOVENT INHALERS-AEM INH-ORL 25MCG/ACTUATION
FLOVENT INHALERS-AEM INH-ORL 25MCG/ACTUATION
Discontinued
DIN Number
02174731
Drug Class
Human
Market Date
Dec 31, 1995
Company
HC
glaxo canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02174731
AIG Number0124685002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA05 FLUTICASONE
Product Specifications
Dosage FormMetered-Dose Aerosol
Route of AdministrationInhalation
,
Oral
AHFS Classification68:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
FLUTICASONE PROPIONATEActive
Strength: 25 MCG / ACT
Monograph: FLUTICASONE PROPIONATE